This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Pascal Simonet
Introduction
Pascal Simonet is a notable inventor based in Villeurbanne, France. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid research. His work has implications for the synthesis of novel compounds, which can be of therapeutic interest.
Latest Patents
Pascal Simonet holds a patent for a method for obtaining nucleic acids from an environmental sample. This method results in nucleic acids that can be used in the synthesis of novel compounds. The invention focuses on preparing a library of nucleic acids from a sample, which can be utilized in various applications, especially in therapeutic contexts. The patent also discusses novel vectors and processes for preparing these vectors, as well as recombinant host cells that contain the nucleic acids. Additionally, methods for detecting specific nucleic acids within the resulting library are included in the patent.
Career Highlights
Pascal Simonet is associated with Aventis Pharma S.A., where he has been able to apply his innovative ideas in a professional setting. His work at the company has allowed him to collaborate with other experts in the field, enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Pascale Jeannin and François Francou. Their collaboration has likely contributed to the advancement of research and development in the biotechnology sector.
Conclusion
Pascal Simonet's contributions to the field of nucleic acids and their applications in novel compound synthesis highlight his innovative spirit and dedication to advancing biotechnology. His patent and work at Aventis Pharma S.A. reflect the importance of collaboration and innovation in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
